For you, by scientists.

In collaboration with leading microbiome scientists and research partners from around the world, we have developed research-backed microbiome testing and lab-made probiotics for outcomes for gastrointestinal, oral, metabolic health and immunity.

Our novel approach entails looking at both blood metabolites and microbes that lead to formation of those metabolites holistically to map metabolic disorders like diabetes, obesity, fatty liver, IBS/IBD, halitosis etc, that are linked to microbes. Our patent has been granted in India, EU, UK and pending grant in US.

Our products are based on global state-of-the-art research and clinically validated with independent research institutes.

Step 1: Review of published research

We have scanned more than 500 research papers and continue to study this field to keep our products up-to-date with the latest research findings. We also contribute to the research by publishing our own findings on a regular basis.

View our published research

Step 2: Clinical collaborations and validations

Our product development is done with research and clinical partners of high repute. These are then validated through a registered clinical trials with large public and private research institutes. 

The results of our patented mathematical models are validated against stool based NGS test as gold standard in clinical trials. We have demonstrated concordance with NGS results in both clinical trials conducted in India at AIIMS, Aster, Maulana Azad Medical College, as well as global datasets from top institutes like Mayo clinic, Broad Institute, Osaka University etc.

While these models give us data about microbiomes and metabolites, a much deeper understanding of their impact on individual bodies is needed to assess health impact. As the understanding of Human biology is evolving, we are keeping pace extending mathematical associations to biological associations enabling rich multi-omics insights into your health.

Step 3: Manufacturing


Our manufacturing involved using strains that have multi-layered coating for long-term viability. They have higher acid and enzyme tolerance and in-built synbiotics making them viable till they reach the site of action. 

 

Step 4: Regulatory and Quality control

The only CDSCO approved microbiome test with CE certified components and DNA sequenced strains

         

 

FSSAI approved strains

Global Quality Adherence

Our probiotics are made in sterilised environment using strains that are extensively tested.

 

Scientific and Clinical Advisory Board

.      .     .   

Dr Palok Aich                          Dr Philip Griebel.             Dr Kishore Behera      Francesco Bellanti

Dean R&D, NISER                  Immunologist, Canada     Endocrinologist.           Endocrinologist

20+ years of research           School of Public Health.   AIIMS Bhubaneshwar      Uni of Foggia, Italy

 

Published research

Book Chapters contributed

  1. Mukhopadhyay S, Ulaganathan N, Dumpuri P, Aich P. Integrative AI-Based Approaches to Connect the Multiome to Use Microbiome-Metabolome Interactive Outcome as Precision Medicine. Methods in Molecular Biology (Clifton, N.J.). 2025
  2. Importance of Microbial Diversity on Health: Perhaps the Best Tool to Intervene in Emerging and Continuing Diseases, Microbial Diversity in the Genomic Era (Second Edition), 2024

Papers and Posters

  1. A Multi-omics Model for IBS Risk Stratification and Clinical Decision Support, World Congress of Gastroenterology, Sep 2026
  2. World Congress of Gastroenterology, Sep 2026
  3. "Blood-Based Metabolomic and Gut Microbiome Profiling in Neurodegenerative Diseases: Two Case Studies Exploring a Minimally-Invasive Approach", Apollo Genomics Conference 2025
  4. Blood drops to gut maps: dried blood spot metabolomics infers gut microbiome composition and guides probiotic intervention in metabolic disease, under review
  5. Targeted Microbiome Modulation for Therapeutic Applications, Indian Society of Gastroenterology Conference, 2022
  6. Predicting Disease States Using Blood Metabolites and Latent Spaces, IBSE, 5th annual conference at IIT-M, Feb 2025
  7. Harnessing AI for Gut Health: Development of a Gut-Specific Chatbot Using llama3, C-DAC 2025 Accelerating Biology 2025: Compute and Transcend